These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19384786)
1. The treatment of choroidal neovascularizations in age-related macular degeneration using either Avastin or Lucentis. Valmaggia C; Haueter I; Kloos P; Lang C; Niederberger H Klin Monbl Augenheilkd; 2009 Apr; 226(4):294-8. PubMed ID: 19384786 [TBL] [Abstract][Full Text] [Related]
2. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA; Retina; 2008; 28(10):1387-94. PubMed ID: 18827735 [TBL] [Abstract][Full Text] [Related]
3. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Algvere PV; Steén B; Seregard S; Kvanta A Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062 [TBL] [Abstract][Full Text] [Related]
4. Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degeneration. Chang TS; Kokame G; Casey R; Prenner J; Feiner L; Anderson N Retina; 2009 Oct; 29(9):1235-41. PubMed ID: 19934818 [TBL] [Abstract][Full Text] [Related]